Roche Holding Aktiengesellschaft - ADR operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Roche Holding Aktiengesellschaft - ADR with three other
companies in this sector in the United States:
Merck & Co. , Inc.
sales of $42.29 billion
of which 89%
was Merck Pharmaceutical),
of which 62%
was Operating Segment-Global Innovative Phar), and
of which 66%
was Innovative Medicines).
Roche Holding Aktiengesellschaft - ADR reported sales of $58.19 billion
December of 2018.
increase of 7.0%
versus 2017, when the company's sales were $54.36 billion.
This was the third consecutive year of growth at Roche Holding Aktiengesellschaft - ADR.
Sales of Pharmaceuticals saw an increase
7.1% in 2018, from
$42.04 billion to $45.01 billion.